10:38:18 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-29 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-05-31 Kvartalsrapport 2024-Q1
2024-05-29 Ordinarie utdelning POLAR 0.00 SEK
2024-05-28 Årsstämma 2024
2024-02-23 Bokslutskommuniké 2023
2023-11-24 Kvartalsrapport 2023-Q3
2023-09-08 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-26 Kvartalsrapport 2023-Q1
2023-05-17 Årsstämma 2023
2023-05-05 Ordinarie utdelning POLAR 0.00 SEK
2023-03-13 Extra Bolagsstämma 2022
2023-02-24 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-27 Kvartalsrapport 2022-Q1
2022-05-06 Ordinarie utdelning POLAR 0.00 SEK
2022-05-05 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-06 Ordinarie utdelning POLAR 0.00 SEK
2021-05-05 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-11-27 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning POLAR 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-29 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2020-02-14 Extra Bolagsstämma 2020
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-05-07 Split POLAR 16:1
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-19 Årsstämma 2019
2019-02-04 Ordinarie utdelning POLAR 0.00 SEK
2019-02-01 Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamt inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2021-04-16 09:02:00

The publication entitled "Selective head-neck cooling after concussion shortens return-to-play in ice hockey players (https://www.futuremedicine.com/doi/10.2217/cnc-2021-0002)" has now been published by Future Medicine in their journal Concussion. The scientific publication is an analysis of data from the study with Swedish Hockey League (SHL) and HockeyAllsvenskan, where a total of 81 cases of concussions are included. The result shows significant positive effects in the form of shortened Return-To-Play (median 7 days for intervention versus 12.5 days for control) and reduced proportion of long-term absence (7% in intervention versus 25% in control) for players cooled with PolarCap® System.

The clinical result of the study opens up the cooling market for concussion treatment, as this is the largest study population in sports-related concussions showing statistically benefits of cooling in treating concussions with the head and neck cooling technology by PolarCap® System. The incidence of sports-related concussions is a significant national health concern and there is growing evidence that repetitive mTBI (mild Traumatic Brain Injury) can cause long-term changes in brain structure and function, not least in ice hockey, and available treatment options are limited.

 

PolarCools CEO Erik Andersson comments:

- We know that the market at an early stage is dependent on medical acceptance. A publication is a proof that the data presented is scientifically relevant. For PolarCool, this means that we have an even stronger tool in our market processing where clinical evidence for treatment with PolarCap® System is a central part. The publication also gives increased weight to the data received after this study, which strengthened the statistical significance regarding the positive effects demonstrated in this study. In several of our conversations with medical representatives, a publication has been requested, which we now have.

This information is information that PolarCool (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out herein, on April 16th, 2021.